Long-term performance of conduction system pacing in patients with congenital heart disease.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Rosés F
- Molina-Lerma M
- de Groot NMS
- Vijayaraman P
- Zemrak F
- BenDavid E
- Rivas-Gándara N
- Misier NR
- Moore JP
Grupos
Abstract
BACKGROUND: Conduction system pacing (CSP) is safe and feasible in congenital heart disease (CHD), but long-term follow-up data remain scarce. OBJECTIVE: This study aimed to evaluate the long-term performance of CSP in patients with CHD. METHODS: This retrospective, multicenter, international study included patients with CHD undergoing CSP-His bundle pacing or left bundle branch area pacing (LBBAP)-with =12-month follow-up. The primary endpoint was survival free from CSP lead-related complications (loss of conduction system capture, pacing threshold =2.5 V or a =2.0 V increase, or lead reintervention). Secondary endpoints included implant success, electrical and echocardiographic outcomes, and clinical status. RESULTS: 144 patients were included (88% moderate/complex CHD; 26% systemic right ventricle; 24% with cardiac resynchronization therapy indication), with 29 His bundle pacing and 115 LBBAP. Acute implant success was 95.1%. Over a median follow-up of 32.2 months (interquartile range 18.2-47.1), survival free from CSP lead-related complications was 0.89, with 88% of CSP lead-related events occurring beyond 12 months of follow-up. Device-related complications occurred in 11.8%, and reinterventions in 5.1%. Microdislodgement (14.6%), threshold increase (6.9%), and loss of conduction system capture (5.6%) were less frequent with LBBAP. Left ventricular ejection fraction improved in patients with systemic left ventricle, whereas patients with a systemic right ventricle preserved fractional area change. Among patients with cardiac resynchronization therapy indications, systemic ventricular function improved from 34% ± 10% to 41% ± 13% (P < .001). CONCLUSION: CSP is feasible across a broad spectrum of CHD and is associated with preservation or improvement of systemic ventricular function. Late lead-related complications are not negligible, underscoring the need for long-term follow-up.
Copyright © 2026 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 1547-5271, 1556-3871
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 42140415
- Factor de Impacto:
- 2,402 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
HEART RHYTHM ELSEVIER SCIENCE INC
Documentos
- No hay documentos
Filiaciones
Keywords
- Cardiac resynchronization therapy; Conduction system pacing; Congenital heart disease; His bundle pacing; Left bundle branch area pacing
Cita
CANO Ó,Rosés F,Molina M,de Groot NMS,Vijayaraman P,Zemrak F,BELTRÁN S,BenDavid E,Rivas N,Misier NR,Moore JP. Long-term performance of conduction system pacing in patients with congenital heart disease. Heart Rhythm. 2026. 23. (10):p. 2532-2542. IF:7,000. (1).
Portal de investigación